HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.
Phytoalexins
Phytoalexins
Phytoalexins are natural compounds produced by plants as part of their defense system to fend off pathogens. When plants encounter bacteria, fungi, or viruses, they respond by synthesizing these antimicrobial substances, which help to contain and prevent the spread of infection. Each plant species creates specific phytoalexins, such as camalexin in Arabidopsis or resveratrol in grapes, each tailored to combat distinct threats. By studying phytoalexins, scientists aim to enhance plant resilience through breeding or genetic engineering, boosting natural disease resistance. This focus on phytoalexins is crucial for agriculture, where healthier, more robust crops can reduce reliance on chemical pesticides.
Committee Members
Srinivasa Rao Mentreddy
Alabama A&M University, United States
Mohammad Babadoost
University of Illinois, United States
Valasia Iakovoglou
UNESCO chair Con-E-Ect, International Hellenic University, Greece GPB 2027 Speakers
Aparna B Gunjal
Dr. D.Y. Patil, Arts, Commerce and Science College, India
Anna Ponce
Bethune-Cookman University, United States
Hillary Jean Pierre
Department of Pharmaceutics, United States
Title : Biovalorization of overripe banana (Musa spp.) extract as a functional ingredient for glycemic regulation in diabesity management
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title :
Valasia Iakovoglou, UNESCO chair Con-E-Ect, International Hellenic University, Greece
Title : The antimicrobial activity of six Ocimum species against human microbial pathogens
Srinivasa Rao Mentreddy, Alabama A&M University, United States
Title : Effect of climate and weather on plant biology and biotechnology
Vijayan Gurumurthy Iyer, Techno-Economic-Environmental Study and Check Consultancy Services, India
Title : Cambial rearrangement in cycads: First evidence from a basal seed plant lineage
Anna Ponce, Bethune-Cookman University, United States
Title : Utilizing plant derived extracellular vesicles for drug delivery and therapeutic development
Hillary Jean Pierre, Department of Pharmaceutics, United States